A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61P 25/24 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2345137
The invention provides the use of selective mGluR5 antagonists for the treatment of pain and anxiety, and the use of mGluR antagonists for the treatment of pain, whereby analgesic effect is achieved by interaction of said antagonists primarily or predominantly at peripheral mGluR receptors.
L'invention porte sur l'utilisation sélective d'antagonistes sélectifs du mGluR5 pour le traitement de la douleur et de l'angoisse et sur l'utilisation d'antagonistes du mGluR pour le traitement de la douleur, leur effet analgésique provenant d'une interaction desdits antagonistes principalement ou de manière prépondérante avec les récepteurs périphériques du mGluR.
Allgeier Hans
Andrew Varney Mark
Cosford Nicholas David
Flor Peter Josef
Gasparini Fabrizio
Fetherstonhaugh & Co.
Novartis Ag
Sibia Neurosciences Inc.
LandOfFree
Mglur5 antagonists for the treatment of pain and anxiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mglur5 antagonists for the treatment of pain and anxiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mglur5 antagonists for the treatment of pain and anxiety will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1702735